Quote | Entrada Therapeutics Inc. (NASDAQ:TRDA)
Last: | $14.63 |
---|---|
Change Percent: | 2.02% |
Open: | $14.78 |
Close: | $14.34 |
High: | $14.85 |
Low: | $14.4 |
Volume: | 15,204 |
Last Trade Date Time: | 05/13/2024 03:00:00 am |
News | Entrada Therapeutics Inc. (NASDAQ:TRDA)
2024-05-09 18:44:45 ET More on Catalyst Pharmaceuticals, Sarepta Therapeutics, etc. Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alter...
2024-05-07 13:53:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Entrada Therapeutics (NASDAQ: TRDA ) just reported results for the first quarter of 2024. Entrada Therapeutics reported earnings per share of 68 cents. This was above the ...
Message Board Posts | Entrada Therapeutics Inc. (NASDAQ:TRDA)
Subject | By | Source | When |
---|---|---|---|
Nice breakout chart | bandit007 | investorshub | 06/27/2022 7:12:23 PM |
IPO > Shares of Entrada Therapeutics Inc. surged | crudeoil24 | investorshub | 10/29/2021 3:59:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Entrada Therapeutics Inc. Company Name:
TRDA Stock Symbol:
NASDAQ Market:
– Initiated dosing of the fourth and final cohort of Phase 1 clinical trial of ENTR-601-44 for the potential treatment of DMD with data readout on track for October of 2024 – – Achieved $75 million milestone payment from Vertex for the clinical advancement o...
2024-04-25 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...